4th Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein patent box draft Tax issues in fiscal cliff legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Health Issues HCR
2013 Sequestration and fiscal cliff issues impacting Medicare, Medicaid and federal health programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.